Transgenomic Receives Warning from Nasdaq for Failing to Maintain Minimum Share Bid Price | GenomeWeb

NEW YORK, Feb. 23 (GenomeWeb News) - Transgenomic has received a letter from the Nasdaq indicating that the company does not comply with the $1 minimum bid price requirement, the company announced today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.